Furthermore, recent evidence has suggested that blocking the OX40-OX40L axis may be an effective strategy for ameliorating autoimmune diseases, including SLE, RA, colitis, and type 1 diabetes mellitus [13, 31–34]. This evidence concerns the gene TNFSF4 and autoimmune disease.